Dong-Dong Wang Selected Research

wuzhi

8/2020	Population pharmacokinetics model and initial dose optimization of tacrolimus in children and adolescents with lupus nephritis based on real-world data.
5/2020	Optimization of initial dosing scheme of tacrolimus in pediatric refractory nephrotic syndrome patients based on CYP3A5 genotype and coadministration with wuzhi-capsule.
5/2020	Initial dosage optimization of tacrolimus in Chinese pediatric patients undergoing kidney transplantation based on population pharmacokinetics and pharmacogenetics.
8/2019	Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dong-Dong Wang Research Topics

Disease

8	Neoplasms (Cancer) 05/2022 - 05/2009
6	Body Weight (Weight, Body) 07/2022 - 05/2020
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 08/2020 - 02/2011
3	Memory Disorders (Memory Loss) 06/2015 - 04/2013
2	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 11/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2022 - 01/2021
2	Lupus Nephritis 02/2021 - 08/2020
2	Obesity 01/2021 - 10/2020
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 11/2018
2	Inflammation (Inflammations) 12/2020 - 03/2015
2	Ischemic Stroke 12/2020 - 01/2019
2	Lymphatic Metastasis 08/2020 - 05/2009
2	Chemical and Drug Induced Liver Injury 05/2020 - 08/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2022
1	Aplastic Anemia (Anemia, Hypoplastic) 07/2022
1	Breast Neoplasms (Breast Cancer) 05/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022
1	Facial Paralysis (Facial Palsy) 03/2021
1	Proteinuria 02/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Infarction (Infarctions) 12/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2020
1	Weight Gain 10/2020
1	Hepatitis 08/2020
1	Neoplasm Metastasis (Metastasis) 08/2020
1	Nephrotic Syndrome (Syndrome, Nephrotic) 05/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 04/2020
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2019
1	Pathologic Constriction (Stenosis) 01/2019
1	Stroke (Strokes) 01/2019
1	Proteostasis Deficiencies 01/2019
1	Sepsis (Septicemia) 12/2018
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2018
1	Urinary Retention 01/2018
1	Constipation 01/2018
1	Nausea 01/2018
1	Neuroblastoma 01/2018
1	Vomiting 01/2018
1	Cancer Pain 01/2018
1	Reperfusion Injury 10/2017

Drug/Important Bio-Agent (IBA)

4	Tacrolimus (Prograf)FDA LinkGeneric 02/2021 - 05/2020
4	wuzhiIBA 08/2020 - 08/2019
4	Capsules (Microcapsules)IBA 08/2020 - 08/2019
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2022 - 04/2020
3	Cytochrome P-450 CYP3AIBA 08/2020 - 05/2020
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2021
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2021 - 10/2017
2	Carnitine (L-Carnitine)FDA LinkGeneric 07/2021 - 01/2021
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 11/2018
2	human ERBB2 proteinIBA 01/2021 - 11/2018
2	Estrogen ReceptorsIBA 01/2021 - 11/2018
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 10/2020
2	Sirolimus (Rapamycin)FDA Link 08/2020 - 01/2020
2	schizandrer AIBA 05/2020 - 08/2019
2	schizandrol BIBA 05/2020 - 08/2019
2	schizandrinIBA 05/2020 - 08/2019
2	Biological ProductsIBA 11/2018 - 06/2008
2	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 01/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2015 - 01/2014
2	Messenger RNA (mRNA)IBA 02/2011 - 05/2009
1	NAD+ Nucleosidase (NAD(P) Nucleosidase)IBA 10/2022
1	PrionsIBA 10/2022
1	Cimetidine (Biomet)FDA LinkGeneric 07/2022
1	CarcinogensIBA 05/2022
1	Long Noncoding RNAIBA 05/2022
1	dihydroceramide desaturaseIBA 05/2022
1	Antisense RNA (Anti-Sense RNA)IBA 05/2022
1	dapagliflozinIBA 02/2022
1	Inosine Triphosphate (ITP)IBA 01/2022
1	SteroidsIBA 01/2022
1	SodiumIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	P-SelectinIBA 01/2022
1	Acetylcarnitine (Alcar)IBA 01/2021
1	Complement C1q (C1q Complement)IBA 12/2020
1	N 30IBA 11/2020
1	Antipsychotic Agents (Antipsychotics)IBA 10/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 08/2020
1	FollistatinIBA 08/2020
1	trans-sodium crocetinate (crocetin)IBA 01/2020
1	Ataxin-7IBA 01/2019
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2019
1	Apolipoproteins B (ApoB)IBA 01/2019
1	ApolipoproteinsIBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	polyglutamineIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2018
1	Biological FactorsIBA 11/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2018
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2018
1	Midazolam (Versed)FDA LinkGeneric 01/2018
1	PotassiumIBA 01/2018
1	Sitagliptin Phosphate (Januvia)FDA Link 10/2017

Therapy/Procedure

1	Glycemic Control 07/2021
1	Meridians (Jing Luo) 03/2021
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2018
1	Therapeutics 12/2018